NT-0001 (BioNTech RNA Pharmaceuticals)

N/A

Report date: 2025/05/14 13:52:04

Base Information

Drug NameNT-0001 (BioNTech RNA Pharmaceuticals)
Drug Alias NamemRNA therapy (BioNTech RNA Pharmaceuticals)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > OligonucleotideCell and gene therapy > Gene therapy > mRNA
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiontech Rna Pharmaceuticals Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiontech Rna Pharmaceuticals Gmbh
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A